References

Cetirizine hydrochloride Summary of Product Characteristics. 2017. Available at www.medicines.org.uk/emc/medicine/29498.

Desloratadine Summary of Product Characteristics. 2016. Available at https://www.medicines.org.uk/emc/product/4888/smpc.

EAACI/GA²LEN/EDF WAO guidelines for chronic spontaneous urticaria. 2017 update: in press.

Ebastine Summary of Product Characteristics. Available at https://mri.cts-mrp.eu/download/DE_H_0742_002_FinalSPC_1of2.pdf.

Fexofenadine Summary of Product Characteristics. 2014. Available at https://www.medicines.org.uk/emc/product/3488/smpc.

Godse KV. Indian J Dermatol 2009; 54(4):310–2.

González-Núñez V et al. Expert Opin Drug Saf 2016; 15:1439–48.

Ilaxten Summary of Product Characteristics. 2017. Available at www.medicines.org.uk/emc/medicine/24461.

Johansson SG et al. J Allergy Clin Immunol 2003; 113(5):832–6.

Kaplan AP. Allergy Asthma Immunol Res 2012; 4(6):326–31.

Kathuria PC. Indian J Allergy Asthma Immunol 2011; 25(1):33–7.

Kolkhir P et al. J Allergy Clin Immunol 2017; 139(6):1772–81.

Lapi F et al. British Journal of Dermatology 2016; 174:996–1004.

Levocetirizine dihydrochloride Summary of Product Characteristics. 2011. Available at https://www.medicines.org.uk/emc/product/5927/smpc.

Loratadine Summary of Product Characteristics. 2018. Available at https://www.medicines.org.uk/emc/product/4501/smpc.

Maurer M et al. Allergy 2011; 66(3):317–30.

Maurer M et al. Allergy 2017; 72(12):2005–16.

Maurer M et al. J Dtsch Dermatol Ges 2013; 11(10):971–7.

Mizollen Summary of Product Characteristics. 2018. Available at https://www.medicines.org.uk/emc/product/363/smpc.

Mullol J et al. Allergy 2015; 70 (Suppl 100):1–24.

Pawankar R et al. World Allergy Organization, White Book on Allergy, 2011.

Rupatadine Summary of Product Characteristics. 2017. Available at https://www.medicines.org.uk/emc/product/2501/smpc.

Waljee AK et al. BMJ 2017;357:j1415.

Zuberbier T et al. Allergy 2018 Jul;73(7):1398–414.

 

Restart Glossary